Kamiren Xl

Doxazosin, the active ingredient in Kamiren XL, is an alpha-1 adrenergic blocker presented as a tablet for oral use. It treats hypertension and benign prostatic hyperplasia in adult patients.

GNH USA supplies Kamiren XL as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Doxazosin is indicated for conditions involving the cardiovascular and urinary systems where alpha‑1 adrenergic blockade is beneficial.

Hypertension: lowers systemic blood pressure and reduces cardiovascular risk. Benign prostatic hyperplasia (BPH): eases urinary obstruction and improves flow. Urinary retention associated with BPH: decreases prostate smooth‑muscle tone to facilitate bladder emptying.

Doxazosin may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness or light‑headedness, especially on standing. - Headache. - Fatigue or weakness. - Nasal congestion. - Peripheral edema. - Nausea.

Serious or Rare Side Effects: - Severe hypotension or syncope. - Priapism. - Acute liver injury. - Allergic reactions such as rash or angioedema.

Before initiating therapy, consider the following safety measures. - Renal impairment: evaluate kidney function and adjust if necessary. - Hepatic impairment: use with caution and monitor liver enzymes. - Concomitant antihypertensives: monitor blood pressure for additive effects. - History of orthostatic hypotension: start at the lowest dose and titrate slowly. - Pregnancy: safety not established; avoid unless clearly needed. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Doxazosin can interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Sildenafil or other PDE5 inhibitors: risk of profound hypotension. - Potassium‑sparing diuretics (e.g., spironolactone): additive blood‑pressure lowering effect.

Moderate Interactions (Monitor Closely):\n- Other antihypertensives (ACE inhibitors, ARBs, beta‑blockers): may enhance blood‑pressure reduction. - Alcohol: can increase dizziness and orthostatic symptoms. - CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): may raise plasma concentrations of doxazosin.